Cargando…
Redundancy and specificity of the metalloprotease system mediating oncogenic NOTCH1 activation in T-ALL
Oncogenic mutations in NOTCH1 are present in over 50% of T-cell lymphoblastic leukemias (T-ALLs). Activation of NOTCH1 requires a double proteolytic processing in the extracellular region of the receptor (S2) and in the transmembrane domain (S3). Currently, anti-NOTCH1 therapies based on inhibition...
Autores principales: | Sulis, Maria Luisa, Saftig, Paul, Ferrando, Adolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165074/ https://www.ncbi.nlm.nih.gov/pubmed/21625236 http://dx.doi.org/10.1038/leu.2011.130 |
Ejemplares similares
-
Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL
por: Antoszewski, Mateusz, et al.
Publicado: (2022) -
Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity
por: Funahashi, Yasuhiro, et al.
Publicado: (2011) -
Redundancy of protein disulfide isomerases in the catalysis of the inactivating disulfide switch in A Disintegrin and Metalloprotease 17
por: Krossa, Sebastian, et al.
Publicado: (2018) -
Notch and its oncogenic activity in human malignancies
por: Brzozowa-Zasada, Marlena, et al.
Publicado: (2017) -
Epidermal ADAM17 is dispensable for Notch activation
por: Groot, Arjan J., et al.
Publicado: (2013)